Skip to content

Research on the topical dosage with a new sunscreen agent

Research on the difference of the topical dosage with a new sunscreen agent before and after external instruction - Research on the difference of the topical dosage with a new sunscreen agent before and after external instruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047866
Enrollment
30
Registered
2022-05-26
Start date
2022-06-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

The research subjects take the test product in the same amount of sunscreen product they daily used, and apply it to the face as usual. After reading the instruction manual for the test product, the r

Sponsors

Non-Profit Organization Health Institute Research of Skin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects of this study are those who meet all of the following criteria. (1) Healthy Japanese men and women who usually use sunscreen (2)Those who are 18 years of age or older on the date of consent acquisition (3)Those who received the explanation of this study, understood and obtained written consent based on their free will. (4)Those who can fill out the documents after understanding the consent form/questionnaire etc. (5) Those who can come to the designated facility on the test day

Exclusion criteria

Exclusion criteria: Subjects with the following exclusion criteria are excluded from the subject of this study. (1)Those who have symptoms such as dermatitis and trauma on the face that are not suitable for the test (2)Those who have had allergic symptoms due to cosmetics, etc. (3)Persons with severe systemic disease (4)Those who are using or receiving treatment for cosmetics, quasi-drugs, or drugs that affect this research. (5)Those who are participating in other clinical studies or clinical trials (6)Others who judged to be inappropriate by the principal investigator

Design outcomes

Primary

MeasureTime frame
Actual topical dosage of the test product per unit area of each research subject in topical application test 1 and 2.

Secondary

MeasureTime frame
(1) Usability immediately after application and 1 hour after application (2) Ease of dropping the test product when washing the face

Countries

Japan

Contacts

Public ContactAkira Nomachi

EBC&M LLC. Project planning and Development department

akira_nomachi@ebc-m.com03-6435-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026